Kathleen Sereda Glaub - Jun 5, 2025 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Kathleen Sereda Glaub
Stock symbol
IOBT
Transactions as of
Jun 5, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 04:26 PM
Previous filing
Jun 7, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glaub Kathleen Sereda Director C/O IO BIOTECH, INC., OLE MAALOES VEJ 3, COPENHAGEN, DENMARK /s/ Brian Burkavage, Attorney-in-Fact for Kathleen Sereda Glaub 2025-06-06 0001619612

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +35.1K $0.00 35.1K Jun 5, 2025 Common Stock 35.1K $1.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.